These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37980185)

  • 21. Promoting global health: utilizing WHO to integrate public health, innovation and intellectual property.
    Mackey TK; Liang BA
    Drug Discov Today; 2012 Dec; 17(23-24):1254-7. PubMed ID: 22728776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spatial differences of foreign capital R&D networks in China: quantitative analysis based on dissipative structure theory.
    Huang X; Zhang P; Liu Q
    Environ Sci Pollut Res Int; 2023 Feb; 30(9):24062-24076. PubMed ID: 36334197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does intellectual property protection promote green innovation in firms? A perspective on R&D spillovers and financing constraints.
    Gao X; Zhao Y
    PLoS One; 2023; 18(11):e0288315. PubMed ID: 37939023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scientists as spies?:
    Vogel KM; Ouagrham-Gormley SB
    Politics Life Sci; 2023 Apr; 42(1):32-64. PubMed ID: 37140223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. China's innovation and research contribution to combating neglected diseases: a secondary analysis of China's public research data.
    Ma J; Zhang L; Li X; Shen J; Sun Y; Huang Y
    Glob Health Res Policy; 2023 Mar; 8(1):6. PubMed ID: 36915177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction to intellectual property rights for investigators in health research and institutional intellectual property policy.
    Shemdoe GS
    Acta Trop; 2009 Nov; 112 Suppl 1():S80-3. PubMed ID: 19682967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consequentialism and the Synthetic Biology Problem.
    Heavey P
    Camb Q Healthc Ethics; 2017 Apr; 26(2):206-229. PubMed ID: 28361719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic biology in the German press: how implications of metaphors shape representations of morality and responsibility.
    Döring M
    Life Sci Soc Policy; 2018 Jun; 14(1):14. PubMed ID: 29936670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intellectual property. Enhanced: intellectual property landscape of the human genome.
    Jensen K; Murray F
    Science; 2005 Oct; 310(5746):239-40. PubMed ID: 16224006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Discussion on exploitation of foreign traditional chinese medicine resources based on "the Belt and Road"].
    Zhang XB; Lyu DM; Huang LQ; Li M; Guo LP; Peng HS
    Zhongguo Zhong Yao Za Zhi; 2018 Apr; 43(7):1501-1506. PubMed ID: 29728043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three synthetic biology applications and their paths to impact in Australia: Cane toads, bacteriophages, and biomining microbes.
    Carter L; Mankad A; Hobman EV; Weynberg KD; Kaksonen AH; Cooper C
    Biotechnol J; 2022 Sep; 17(9):e2200009. PubMed ID: 35652854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRIPS-plus and access to medicines in China.
    Chen J; Nie X; Yao P; Shi L
    J Public Health Policy; 2013 May; 34(2):226-38. PubMed ID: 23552834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global health and Brazilian foreign policy: the negotiations on innovation and intellectual property.
    Lima JHDS
    Cien Saude Colet; 2017 Jul; 22(7):2213-2221. PubMed ID: 28724003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Policy experimentation and innovation as a response to complexity in China's management of health reforms.
    Husain L
    Global Health; 2017 Aug; 13(1):54. PubMed ID: 28774319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Position and enforcement practice of the People's Republic of China's pharmaceutical data exclusivity protection.
    Li N; Yu X; Pecht M
    Drug Des Devel Ther; 2016; 10():2015-20. PubMed ID: 27382254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intellectual Property in Facial Plastic and Reconstructive Surgery: The Importance and Process of Obtaining Intellectual Property Rights.
    Razavi CR; Byrne PJ
    Facial Plast Surg; 2023 Oct; 39(5):460-465. PubMed ID: 37196666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A database linking Chinese patents to China's census firms.
    He ZL; Tong TW; Zhang Y; He W
    Sci Data; 2018 Mar; 5():180042. PubMed ID: 29583142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot oral history of plant synthetic biology.
    Joshi J; Hanson AD
    Plant Physiol; 2024 Apr; 195(1):36-47. PubMed ID: 38163646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patents: Protecting China's national treasure.
    Jiang J
    Nature; 2011 Dec; 480(7378):S93. PubMed ID: 22190090
    [No Abstract]   [Full Text] [Related]  

  • 40. Intellectual Property Rights: Protection of Biotechnological Inventions in India.
    Gomase V; Kemkar K; Potnis V
    Recent Pat Biotechnol; 2024; 18(2):128-143. PubMed ID: 38282443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.